FDA approval confirms its effectiveness, but its not a miracle drug
About 50% of men have the condition at age 50, and the percentage increases with age
Moderate weight loss was found to be a common side effect of the drug, and the FDA approved a different formulation of semaglutide, called Wegovy, for that purpose in 2021
Am J Clin Nutr 118(3):614626 Peterson SC, Barry AR (2018) Effect of glucagon-like peptide-1 receptor agonists on all-cause mortality and cardiovascular outcomes: a meta-analysis
These drugs slow gastric emptying, which can cause a prolonged sensation of fullness and a reduced desire to drink fluids
Typically, you keep access until the end of the current billing periodconfirm inside your account after canceling